VERICEL CORPORATION Tax Withholding Paid on Stock Awards
VERICEL CORPORATION (VCEL) reported Tax Withholding Paid on Stock Awards of $4.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-30
- VERICEL CORPORATION payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $143.00K, a 5.15% increase year-over-year.
- VERICEL CORPORATION payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $4.52M, a 27.16% decline year-over-year.
- VERICEL CORPORATION payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $169.00K, a 10.46% increase year-over-year.
- VERICEL CORPORATION payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $305.00K, a 12.55% increase year-over-year.
- VERICEL CORPORATION payment, tax withholding, share-based payment arrangement for fiscal 2025 was $6.82M, a 24.81% increase from fiscal 2024.
- VERICEL CORPORATION payment, tax withholding, share-based payment arrangement for fiscal 2024 was $5.46M, a 133.32% increase from fiscal 2023.
- VERICEL CORPORATION payment, tax withholding, share-based payment arrangement for fiscal 2023 was $2.34M, a 56.90% increase from fiscal 2022.
- VERICEL CORPORATION payment, tax withholding, share-based payment arrangement for fiscal 2022 was $1.49M, a 10.39% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $143.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $4.66M 10-Q · filed 2026-07-30 | $4.83M derived: sum of 3 quarters · filed 2026-07-30 | $5.14M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $4.52M 10-Q · filed 2026-05-07 | $4.69M derived: sum of 2 quarters · filed 2026-05-07 | $5.00M derived: sum of 3 quarters · filed 2026-05-07 | $5.13M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $474.00K derived: sum of 2 quarters · filed 2026-02-26 | $610.00K derived: sum of 3 quarters · filed 2026-07-30 | $6.82M 10-K · filed 2026-02-26 |
| 2025-09-30 | $305.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $441.00K derived: sum of 2 quarters · filed 2026-07-30 | $6.65M 10-Q · filed 2025-11-06 | $6.80M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $136.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $6.34M 10-Q · filed 2026-07-30 | $6.50M derived: sum of 3 quarters · filed 2026-07-30 | $6.77M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $6.21M 10-Q · filed 2026-05-07 | $6.36M derived: sum of 2 quarters · filed 2026-05-07 | $6.63M derived: sum of 3 quarters · filed 2026-05-07 | $6.77M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $153.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $424.00K derived: sum of 2 quarters · filed 2026-02-26 | $562.00K derived: sum of 3 quarters · filed 2026-02-26 | $5.46M 10-K · filed 2026-02-26 |
| 2024-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $409.00K derived: sum of 2 quarters · filed 2025-11-06 | $5.31M 10-Q · filed 2025-11-06 | $5.39M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $138.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $5.04M 10-Q · filed 2025-07-31 | $5.12M derived: sum of 3 quarters · filed 2026-02-26 | $5.20M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $4.90M 10-Q · filed 2025-05-08 | $4.98M derived: sum of 2 quarters · filed 2026-02-26 | $5.07M derived: sum of 3 quarters · filed 2026-02-26 | $5.14M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $165.00K derived: sum of 2 quarters · filed 2026-02-26 | $244.00K derived: sum of 3 quarters · filed 2026-02-26 | $2.34M 10-K · filed 2026-02-26 |
| 2023-09-30 | $86.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $165.00K derived: sum of 2 quarters · filed 2024-11-07 | $2.26M 10-Q · filed 2024-11-07 | $2.27M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $2.18M 10-Q · filed 2024-08-01 | $2.18M derived: sum of 3 quarters · filed 2025-02-27 | $2.23M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $2.10M 10-Q · filed 2024-05-08 | $2.10M derived: sum of 2 quarters · filed 2025-02-27 | $2.15M derived: sum of 3 quarters · filed 2025-02-27 | $2.65M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $51.00K derived: sum of 2 quarters · filed 2025-02-27 | $549.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.49M 10-K · filed 2025-02-27 |
| 2022-09-30 | $44.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $542.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.49M 10-Q · filed 2023-11-08 | $1.53M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $498.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $1.44M 10-Q · filed 2023-08-02 | $1.49M derived: sum of 3 quarters · filed 2024-02-29 | $1.54M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $943.00K 10-Q · filed 2023-05-10 | $989.00K derived: sum of 2 quarters · filed 2024-02-29 | $1.05M derived: sum of 3 quarters · filed 2024-02-29 | $1.11M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $46.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $103.00K derived: sum of 2 quarters · filed 2024-02-29 | $164.00K derived: sum of 3 quarters · filed 2024-02-29 | $1.67M 10-K · filed 2024-02-29 |
| 2021-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $118.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.62M 10-Q · filed 2022-11-09 | $1.62M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $1.56M 10-Q · filed 2022-08-03 | $1.56M derived: sum of 3 quarters · filed 2023-02-23 | $1.56M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.50M 10-Q · filed 2022-05-04 | $1.50M derived: sum of 2 quarters · filed 2023-02-23 | $1.50M derived: sum of 3 quarters · filed 2023-02-23 | $1.57M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $0.00 derived: sum of 2 quarters · filed 2023-02-23 | $66.00K derived: sum of 3 quarters · filed 2023-02-23 | $163.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $66.00K derived: sum of 2 quarters · filed 2021-11-09 | $163.00K 10-Q · filed 2021-11-09 | $163.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $66.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $163.00K 10-Q · filed 2021-08-04 | $163.00K derived: sum of 3 quarters · filed 2022-02-24 | $163.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $97.00K 10-Q · filed 2021-05-05 | $97.00K derived: sum of 2 quarters · filed 2022-02-24 | $97.00K derived: sum of 3 quarters · filed 2022-02-24 | $97.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 derived: sum of 2 quarters · filed 2022-02-24 | $0.00 derived: sum of 3 quarters · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |